Hi Dr. Jain and congratulations on your new role at CareMore!
I am curious what you think of the recent discovery of teixobactin, the new antibiotic developed by Northeastern and Novobiotic. (link: nbcnews.com/health/health-news...) They seem to have designed a new model for cell culturing that allows for growth and subsequent research on previously inaccessible bacterial strains.
How do you see this discovery changing our current drug development process and have you seen any other technologies which have show similarly "game-changing" prospects?
Thanks in advance!